Opus Genetics Inc (IRD)

09:31 AM

Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc. - The Manila Times

09:31 AM

09:31 AM

Portland Investment Counsel Inc. Recognized at the FundGrade A+® Awards - The Manila Times

09:31 AM

08:51 AM

Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing - The Manila Times

08:51 AM

Jan 25, 2025

Opus Genetics sets April 30 for 2025 Annual Meeting - MSN

Jan 25, 2025

Jan 25, 2025

Opus Genetics revises executive compensation agreements - Investing.com India

Jan 25, 2025

Jan 24, 2025

Avinger Inc adjourns Special Meeting due to lack of quorum - MSN

Jan 24, 2025

Jan 24, 2025

Opus Genetics revises executive compensation agreements By Investing.com - Investing.com Canada

Jan 24, 2025

Jan 24, 2025

Opus Genetics Enhances Executive Severance Packages - TipRanks

Jan 24, 2025

Jan 24, 2025

Applied DNA Sciences fails to secure shareholder vote - MSN

Jan 24, 2025

Jan 22, 2025

Harmony Biosciences Reports Strong Revenue Growth and Outlines Ambitious 2025 Strategy - MSN

Jan 22, 2025

Jan 22, 2025

Toyota Tsusho (OTCMKTS:TYHOF) Shares Down 18.7% – Should You Sell? - Defense World

Jan 22, 2025

Jan 14, 2025

Opus Genetics launches $40M at-the-market equity program - Investing.com

Jan 14, 2025

Jan 13, 2025

NeoGenomics CEO Chris Smith to retire - MSN

Jan 13, 2025

Dec 30, 2024

Opus Genetics CEO Magrath George buys $97,600 in stock - Investing.com

Dec 30, 2024

Dec 20, 2024

Top 10 Small-Cap Stocks to Watch in 2025 - Investing.com

Dec 20, 2024

Dec 20, 2024

Top 10 Small-Cap Stocks to Watch in 2025 - Investing.com

Dec 20, 2024

Dec 20, 2024

Opus Genetics aligns with FDA on Phase 3 trial for diabetic retinopathy drug - Investing.com Canada

Dec 20, 2024

Dec 19, 2024

IRD stock touches 52-week low at $0.84 amid market challenges - Investing.com India

Dec 19, 2024

Dec 19, 2024

Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy - The Manila Times

Dec 19, 2024

Dec 19, 2024

Opus Genetics Secures FDA Agreement for Pivotal Diabetic Retinopathy Treatment Trial - StockTitan

Dec 19, 2024

Dec 16, 2024

Ocuphire Pharma Sets End-of-Phase 2 Meeting With FDA in Q4 to Discuss Diabetic Retinopathy Treatment - Marketscreener.com

Dec 16, 2024

Dec 14, 2024

Opus Genetics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 - Marketscreener.com

Dec 14, 2024

Dec 03, 2024

Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a - GlobeNewswire

Dec 03, 2024

Dec 03, 2024

Opus Genetics, Inc. to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024 - Marketscreener.com

Dec 03, 2024

Nov 28, 2024

AXT Inc (AXTI) Could Be Worth Considering For The Next Few Weeks - Stocks Register

Nov 28, 2024

Nov 28, 2024

At $0.76 Price, Cumulus Media Inc (CMLS) Is Sitting And Waiting - Stocks Register

Nov 28, 2024

Nov 28, 2024

Analysts Update Their Estimates For Alpha Teknova Inc - Stocks Register

Nov 28, 2024

Nov 28, 2024

Analysts Provide An Important Insights On Hallador Energy Co (HNRG) - Stocks Register

Nov 28, 2024

Nov 28, 2024

Hippo Holdings Inc (HIPO): Major Improvements, Worth A Look - Stocks Register

Nov 28, 2024

Nov 28, 2024

Telomir Pharmaceuticals Inc (TELO) Recovers 37.62% From Low: Are We There Yet? - Stocks Register

Nov 28, 2024

Nov 28, 2024

Journey Medical Corp (DERM) Should Be Considered For The Next Few Weeks - Stocks Register

Nov 28, 2024

Nov 28, 2024

The9 Limited ADR (NCTY)’S 0.19% Increase Makes It Worth Considering Again - Stocks Register

Nov 28, 2024

Nov 28, 2024

Platinum Group Metals Ltd (PLG): Be Patient, You Will Learn - Stocks Register

Nov 28, 2024

Nov 28, 2024

Nexgel Inc (NXGL) Is On The Launchpad, Waiting For Long-Term Buyers. - Stocks Register

Nov 28, 2024

Nov 28, 2024

Cel-Sci Corp (CVM) Stock Behavior Is Not Predictable - Stocks Register

Nov 28, 2024

Nov 26, 2024

Opus Genetics president Benjamin Yerxa acquires $9,834 in stock - Investing.com India

Nov 26, 2024

Nov 25, 2024

Opus Genetics president Benjamin Yerxa acquires $9,834 in stock By Investing.com - Investing.com Canada

Nov 25, 2024

Nov 20, 2024

Opus Genetics Inc CEO George Magrath Purchases 100,000 Shares - GuruFocus.com

Nov 20, 2024

Nov 16, 2024

FY2024 EPS Estimates for Opus Genetics Cut by HC Wainwright - Defense World

Nov 16, 2024

Nov 14, 2024

Opus Genetics Inc (IRD) Quarterly 10-Q Report - Quartzy

Nov 14, 2024

Nov 14, 2024

Opus Genetics reinstated with a Buy at H.C. Wainwright - Yahoo Finance

Nov 14, 2024

Nov 13, 2024

IRD stock touches 52-week low at $1.07 amid market challenges - Investing.com India

Nov 13, 2024

Nov 13, 2024

Opus Genetics (IRD) Stock Chart and Price History 2024 - MarketBeat

Nov 13, 2024

Nov 13, 2024

Wainwright sets stock target on Opus Genetics, cites 2025 catalysts By Investing.com - Investing.com UK

Nov 13, 2024

Nov 13, 2024

Opus Genetics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Opus Genetics Reports $7.5 Million Net Loss in Third Quarter - Vision Monday

Nov 13, 2024

Nov 12, 2024

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Nov 12, 2024

Nov 12, 2024

Opus Genetics, Inc. (IRD) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 12, 2024

Nov 06, 2024

Hafnia Ltd (NYSE: HAFN) Drops -3.00%, Turning Investors Away - Stocks Register

Nov 06, 2024

Oct 30, 2024

If You Don’t Buy Zimmer Biomet Holdings Inc (NYSE: ZBH) Now, You’ll Regret It Later - Stocks Register

Oct 30, 2024

Oct 25, 2024

The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics - Lelezard

Oct 25, 2024

Oct 25, 2024

Ocuphire Pharma Acquires Opus Genetics - Marketscreener.com

Oct 25, 2024